171 related articles for article (PubMed ID: 15685486)
21. In vitro validation of a Respimat® adapter for delivery of inhaled bronchodilators during mechanical ventilation.
Dellweg D; Wachtel H; Höhn E; Pieper MP; Barchfeld T; Köhler D; Glaab T
J Aerosol Med Pulm Drug Deliv; 2011 Dec; 24(6):285-92. PubMed ID: 21870959
[TBL] [Abstract][Full Text] [Related]
22. What plays a role in the choice of inhaler device for asthma therapy?
Virchow JC
Curr Med Res Opin; 2005; 21 Suppl 4():S19-25. PubMed ID: 16138941
[TBL] [Abstract][Full Text] [Related]
23. Acute local tolerability of acidic aqueous vehicles delivered via Respimat Soft Mist Inhaler in hyperreactive asthma patients.
Leclerc V; Lafferre M; Pavia D
Respiration; 2007; 74(6):691-6. PubMed ID: 17728532
[TBL] [Abstract][Full Text] [Related]
24. Clinical efficacy and safety of the combination of ipratropium bromide and fenoterol inhaled via the Respimat Soft Mist inhaler for relief of airflow obstruction.
Vincken W
Expert Rev Respir Med; 2008 Feb; 2(1):11-26. PubMed ID: 20477218
[TBL] [Abstract][Full Text] [Related]
25. The Respimat
Iwanaga T; Tohda Y; Nakamura S; Suga Y
Clin Drug Investig; 2019 Nov; 39(11):1021-1030. PubMed ID: 31377981
[TBL] [Abstract][Full Text] [Related]
26. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
Onoue S; Misaka S; Kawabata Y; Yamada S
Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
[TBL] [Abstract][Full Text] [Related]
27. Factors guiding the choice of delivery device for inhaled corticosteroids in the long-term management of stable asthma and COPD: focus on budesonide.
Thorsson L; Geller D
Respir Med; 2005 Jul; 99(7):836-49. PubMed ID: 15939245
[TBL] [Abstract][Full Text] [Related]
28. Can patients use all dry powder inhalers equally well?
Gustafsson P; Taylor A; Zanen P; Chrystyn H
Int J Clin Pract Suppl; 2005 Dec; (149):13-8. PubMed ID: 16279998
[TBL] [Abstract][Full Text] [Related]
29. Optimizing the in vitro performance of Respimat.
Zierenberg B
J Aerosol Med; 1999; 12 Suppl 1():S19-24. PubMed ID: 10623337
[TBL] [Abstract][Full Text] [Related]
30. [Influence of inhaler and fine particle on efficacy of inhalation therapy in COPD].
Sliwiński P; Chazan R; Dąbrowiecki P; Jahnz-Różyk K; Mróz R; Pirożyński M
Pneumonol Alergol Pol; 2014; 82(3):300-10. PubMed ID: 24793155
[TBL] [Abstract][Full Text] [Related]
31. Requirements, Strengths and Weaknesses of Inhaler Devices for COPD Patients from the Expert Prescribers' Point of View: Results of the EPOCA Delphi Consensus.
García-Río F; Soler-Cataluña JJ; Alcazar B; Viejo JL; Miravitlles M
COPD; 2017 Dec; 14(6):573-580. PubMed ID: 28891722
[TBL] [Abstract][Full Text] [Related]
32. How to achieve good compliance and adherence with inhalation therapy.
Molimard M
Curr Med Res Opin; 2005; 21 Suppl 4():S33-7. PubMed ID: 16138943
[TBL] [Abstract][Full Text] [Related]
33. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler.
Geller DE
Respir Care; 2005 Oct; 50(10):1313-21; discussion 1321-2. PubMed ID: 16185367
[TBL] [Abstract][Full Text] [Related]
34. Experimental Study of Spiriva Respimat Soft Mist Inhaler Spray Characterization: Size Distributions and Velocity.
Alatrash A; Mehri R; Ogrodnik N; Matida E; Fiorenza F
J Aerosol Med Pulm Drug Deliv; 2019 Oct; 32(5):293-302. PubMed ID: 31259646
[No Abstract] [Full Text] [Related]
35. Novolizer: the new technology for the management of asthma therapy.
Köhler D
Curr Opin Pulm Med; 2003 Apr; 9 Suppl 1():S11-6. PubMed ID: 12974537
[TBL] [Abstract][Full Text] [Related]
36. Clinical implications of the tiotropium/olodaterol inhaler for patients with chronic obstructive pulmonary disease.
Ferguson GT; Dalby RN
Postgrad Med; 2018 Aug; 130(6):515-522. PubMed ID: 29972656
[TBL] [Abstract][Full Text] [Related]
37. Aerosol delivery devices in the treatment of asthma.
Hess DR
Respir Care; 2008 Jun; 53(6):699-723; discussion 723-5. PubMed ID: 18501026
[TBL] [Abstract][Full Text] [Related]
38. Dry powder inhalers: an overview.
Atkins PJ
Respir Care; 2005 Oct; 50(10):1304-12; discussion 1312. PubMed ID: 16185366
[TBL] [Abstract][Full Text] [Related]
39. Measurement of peak inspiratory flow with in-check dial device to simulate low-resistance (Diskus) and high-resistance (Turbohaler) dry powder inhalers in children with asthma.
Amirav I; Newhouse MT; Mansour Y
Pediatr Pulmonol; 2005 May; 39(5):447-51. PubMed ID: 15765541
[TBL] [Abstract][Full Text] [Related]
40. Idealhalers or realhalers? A comparison of Diskus and Turbuhaler.
Borgström L; Asking L; Thorsson L
Int J Clin Pract; 2005 Dec; 59(12):1488-95. PubMed ID: 16351685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
